SCHEMBL30926709

SCHEMBL30926709

CC(=O)c1cccc(NS(=O)(=O)c2cc(C(=O)Nc3cccc([N+](=O)[O-])c3)ccc2C)c1

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.87
▸ KMT2A Q03164 9/20 0.87
▸ MAPT P10636 9/20 0.80
▸ SMN1; SMN2 Q16637 5/20 0.80
▸ LMNA P02545 4/20 0.80
▸ ALDH1A1 P00352 4/20 0.80
▸ POLB P06746 2/20 0.79
▸ MAPK1 P28482 2/20 0.75
▸ HTT P42858 1/20 0.75
▸ CASP3 P42574 1/20 0.63
▸ SENP8 Q96LD8 1/20 0.63
▸ SENP7 Q9BQF6 1/20 0.63
▸ SENP6 Q9GZR1 1/20 0.63
▸ IDH1 O75874 1/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ BLM P54132 1/20 0.59
▸ KDM4E B2RXH2 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ PTGER4 P35408 1/20 0.57
▸ NPC1 O15118 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179683 1.00 MEN1 (0.87) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL30926529 0.91 MAPT (0.85) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL27180025 0.91 MAPT (0.85) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL27180386 0.91 MAPT (0.92) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL30926946 0.89 MEN1 (0.79) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL27181608 0.89 MEN1 (0.79) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL27180922 0.89 MAPT (1.00) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL27180448 0.88 ALDH1A1 (1.00) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL30926692 0.87 MAPT (0.85) MEN1KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL30926792 0.87 MAPT (0.85) MEN1KMT2AMAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885MAPT 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback